We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

Identifying a Microbial Needle in a Sample Haystack
Industry Insight

We spoke to Dr Jack Regan, CEO of LexaGene, a biotechnology company developing a fully automated pathogen detection platform, and inventor of their patented microfluidic system, about the foundations and evolution of the system, and the future outlook for the tool.

Read More

Deciphering RNA to Predict if a Patient Will Respond to a Targeted Drug
Industry Insight

We recently spoke to Alif Saleh, CEO of Scipher Medicine to learn how RNA data from a patient’s blood sample can be used to determine the underlying molecular processes driving a disease, and establish how well a patient will respond to a particular therapy.

Read More

Microfluidics Solutions to Proteomics Problems
Industry Insight

Microfluidic platforms are becoming commonplace across biological science. To find out more about how microfluidic technology is revolutionizing protein analysis, we spoke to Tuomas Knowles, Founder and Chief Scientific Officer, Fluidic Analytics.

Read More

Building a Smart City
Industry Insight

Cities often don't work very well. Bins don't get collected. Traffic queues are long. Shops run out of goods. The Russian team behind Airalab think that AI can help streamline cities and the economy more widely. Their Robonomics platform aims to make it easier to bring automated, intelligent technology into the economy. With Smart City projects already on the go, from Dubai to Milton Keynes, we spoke to Airalab's Aleksandr Kapitonov to find out more.

Read More

Genomics Assures Customers About the Source of Their Meat
Industry Insight

How can meat processors and retailers assure their customers that the meat they are buying is what is declared on the packaging? A genetic fingerprinting system is now on hand to provide definitive, traceable evidence.

Read More

Brain Injury Diagnosed With Single Drop of Blood: a Follow-up
Industry Insight

What do biomarkers and a 1990s TGIF party have in common? Find out here...
TBIcheck is a rapid point-of-care diagnostic device that detects biomarkers indicative of mild traumatic brain injury. To find out more, we spoke with the head of the Biomedical Proteomics Group, Jean-Charles Sanchez.

Read More

Tandem Mass Spectrometry: Rising to Challenges in Clinical Labs
Industry Insight

Assay sensitivity and specificity continues to be a challenge in measuring hormones at low concentrations. Tandem mass spectrometry offers significant advantages - particularly in a clinical setting, where speed and sensitivity are required. Following SCIEX' launch of a new tandem mass spectrometry system, we spoke with Michael Jarvis, Product Manager at SCIEX, to find out more.

Read More

Combating Neurodegenerative and Age-related Diseases
Industry Insight

We recently spoke to Karoly Nikolich, chairman and chief executive officer of Alkahest, a clinical-stage biotechnology company, to learn more about their approach to developing therapeutics for both neurodegenerative and age-related diseases.

Read More

Assembling the Pieces of the Genomic Puzzle
Industry Insight

OmniTier Inc.’s new bioinformatics platform, CompStorTM Novos, takes a de novo assembly-based variant calling approach to the challenge of whole genome sequencing. We caught up with Jon Coker, Omnitier’s CTO, to discuss how this approach matches up to rival techniques, and how high-performance computing approaches like Omnitier’s hope to bring personalized medicine a step closer and boost biology in coming years.

Read More

Immunotherapy Response Prediction in Urothelial Cancer
Industry Insight

While immunotherapy holds great promise for cancer treatment, challenges persist around limited response rate and severe immune-related adverse events. We caught up with Dr. Georg Lautscham, CEO of Protagen, to find out how the prediction of immunotherapy response can be improved for people with urothelial cancer.

Read More

 
Advertisement